InMode Ltd. (INMD)

G1 Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	401.56	394.82	492.05	454.27	357.57	206.11
Revenue Growth (YoY)	-3.62%	-19.76%	8.32%	27.05%	73.48%	31.81%
Cost of Revenue	80.39	77.75	80.71	73.49	53.59	30.85
Gross Profit	321.18	317.07	411.34	380.79	303.97	175.26
Selling, General & Admin	194.36	191.4	202.27	170.51	127.76	92.95
Research & Development	12.19	13.14	13.41	12.43	9.53	9.47
Other Operating Expenses	-	-	-	-	-0.8	-
Operating Expenses	206.55	204.54	215.68	182.93	136.5	102.42
Operating Income	114.62	112.53	195.66	197.85	167.48	72.84
Interest & Investment Income	31.78	33.54	21.13	3.68	0.7	3.3
Other Non Operating Income (Expenses)	-2.43	-2.43	0.48	-	-	-
EBT Excluding Unusual Items	143.98	143.64	217.27	201.54	168.18	76.14
Gain (Loss) on Sale of Investments	-0.17	-0.17	-	-0.07	-0.18	-0.01
Pretax Income	143.81	143.47	217.27	201.47	168	76.13
Income Tax Expense	-34.9	-37.81	19.35	39.95	2.93	1.11
Earnings From Continuing Operations	178.7	181.28	197.92	161.52	165.07	75.03
Minority Interest in Earnings	-	-	-	-	-0.1	0.01
Net Income	178.7	181.28	197.92	161.52	164.97	75.03
Net Income to Common	178.7	181.28	197.92	161.52	164.97	75.03
Net Income Growth	19.78%	-8.41%	22.54%	-2.09%	119.87%	22.71%
Shares Outstanding (Basic)	70	79	84	82	81	72
Shares Outstanding (Diluted)	71	81	86	85	86	84
Shares Change (YoY)	-18.30%	-6.23%	0.64%	-0.71%	2.18%	10.60%
EPS (Basic)	2.55	2.29	2.37	1.96	2.03	1.04
EPS (Diluted)	2.54	2.25	2.30	1.89	1.92	0.89
EPS Growth	46.63%	-2.17%	21.69%	-1.56%	115.73%	11.25%
Free Cash Flow	103.99	132	176.12	180	173.95	78.76
Free Cash Flow Per Share	1.47	1.64	2.05	2.11	2.02	0.94
Gross Margin	79.98%	80.31%	83.60%	83.82%	85.01%	85.03%
Operating Margin	28.54%	28.50%	39.76%	43.55%	46.84%	35.34%
Profit Margin	44.50%	45.91%	40.22%	35.56%	46.14%	36.40%
Free Cash Flow Margin	25.90%	33.43%	35.79%	39.63%	48.65%	38.21%
EBITDA	115.38	113.26	196.28	198.53	167.99	73.26
EBITDA Margin	28.73%	28.69%	39.89%	43.70%	46.98%	35.54%
D&A For EBITDA	0.75	0.73	0.62	0.68	0.52	0.42
EBIT	114.62	112.53	195.66	197.85	167.48	72.84
EBIT Margin	28.54%	28.50%	39.76%	43.55%	46.84%	35.34%
Effective Tax Rate	-	-	8.91%	19.83%	1.74%	1.45%
Advertising Expenses	-	15	15	10	4	5

Updated Jul 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q